|
US320706A
(en)
*
|
|
1885-06-23 |
|
Mechanical movement |
|
CA1146866A
(en)
|
1979-07-05 |
1983-05-24 |
Yamanouchi Pharmaceutical Co. Ltd. |
Process for the production of sustained release pharmaceutical composition of solid medical material
|
|
US4327725A
(en)
|
1980-11-25 |
1982-05-04 |
Alza Corporation |
Osmotic device with hydrogel driving member
|
|
US4624848A
(en)
|
1984-05-10 |
1986-11-25 |
Ciba-Geigy Corporation |
Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
|
|
GB8518301D0
(en)
|
1985-07-19 |
1985-08-29 |
Fujisawa Pharmaceutical Co |
Hydrodynamically explosive systems
|
|
US5011692A
(en)
|
1985-12-28 |
1991-04-30 |
Sumitomo Pharmaceuticals Company, Limited |
Sustained pulsewise release pharmaceutical preparation
|
|
US4968509A
(en)
|
1987-07-27 |
1990-11-06 |
Mcneilab, Inc. |
Oral sustained release acetaminophen formulation and process
|
|
IL92966A
(en)
|
1989-01-12 |
1995-07-31 |
Pfizer |
Dispensing devices powered by hydrogel
|
|
US5017381A
(en)
|
1990-05-02 |
1991-05-21 |
Alza Corporation |
Multi-unit pulsatile delivery system
|
|
WO1992018106A1
(fr)
|
1991-04-16 |
1992-10-29 |
Nippon Shinyaku Co., Ltd. |
Procede de production d'une dispersion solide
|
|
HU227530B1
(en)
|
1991-11-22 |
2011-07-28 |
Warner Chilcott Company |
Delayed-release compositions containing risedronate and process for their production
|
|
US5229135A
(en)
|
1991-11-22 |
1993-07-20 |
Prographarm Laboratories |
Sustained release diltiazem formulation
|
|
US5340591A
(en)
|
1992-01-24 |
1994-08-23 |
Fujisawa Pharmaceutical Co., Ltd. |
Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine
|
|
US5461140A
(en)
|
1992-04-30 |
1995-10-24 |
Pharmaceutical Delivery Systems |
Bioerodible polymers for solid controlled release pharmaceutical compositions
|
|
US5260068A
(en)
|
1992-05-04 |
1993-11-09 |
Anda Sr Pharmaceuticals Inc. |
Multiparticulate pulsatile drug delivery system
|
|
AU4198793A
(en)
|
1992-07-24 |
1994-01-27 |
Takeda Chemical Industries Ltd. |
Microparticle preparation and production thereof
|
|
US5700485A
(en)
|
1992-09-10 |
1997-12-23 |
Children's Medical Center Corporation |
Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
|
|
JP2616252B2
(ja)
|
1992-10-16 |
1997-06-04 |
日本新薬株式会社 |
ワックスマトリックスの製法
|
|
US5260069A
(en)
|
1992-11-27 |
1993-11-09 |
Anda Sr Pharmaceuticals Inc. |
Pulsatile particles drug delivery system
|
|
US5322655A
(en)
|
1993-02-19 |
1994-06-21 |
Thomas Engineering, Inc. |
Method for monitoring and controlling the weights of each layer of a multilayer tablet
|
|
US5686105A
(en)
|
1993-10-19 |
1997-11-11 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
|
|
US5567441A
(en)
|
1995-03-24 |
1996-10-22 |
Andrx Pharmaceuticals Inc. |
Diltiazem controlled release formulation
|
|
JPH11505258A
(ja)
|
1995-05-17 |
1999-05-18 |
セダーシナイ メディカル センター |
小腸における消化および吸収を改善させる脂肪酸を含む組成物
|
|
US5837284A
(en)
|
1995-12-04 |
1998-11-17 |
Mehta; Atul M. |
Delivery of multiple doses of medications
|
|
US5840329A
(en)
|
1997-05-15 |
1998-11-24 |
Bioadvances Llc |
Pulsatile drug delivery system
|
|
ATE400252T1
(de)
|
1999-02-10 |
2008-07-15 |
Pfizer Prod Inc |
Pharmazeutische feste dispersionen
|
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
US6465014B1
(en)
|
2001-03-21 |
2002-10-15 |
Isp Investments Inc. |
pH-dependent sustained release, drug-delivery composition
|
|
IL165383A0
(en)
|
2002-06-21 |
2006-01-15 |
Transform Pharmaceuticals Inc |
Pharmaceutical compositions with improved dissolution
|
|
JP4472691B2
(ja)
|
2003-02-21 |
2010-06-02 |
キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ |
神経変性疾患の処置のための１−フェニルアルカンカルボン酸誘導体
|
|
WO2009133128A1
(en)
|
2008-04-29 |
2009-11-05 |
Pharnext |
Combination compositions for treating alzheimer disease and related disorders with zonisamide and acamprosate
|
|
EP2133322A1
(en)
|
2008-06-11 |
2009-12-16 |
CHIESI FARMACEUTICI S.p.A. |
Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid
|
|
ES2437163T3
(es)
|
2009-08-04 |
2014-01-09 |
Chiesi Farmaceutici S.P.A. |
Procesos para la preparación de derivados del ácido 1-(2-halobifenil-4-il)-ciclopropanocarboxílico
|
|
US9592210B2
(en)
|
2011-12-22 |
2017-03-14 |
Chiesi Farmaceutici S.P.A. |
1-phenylalkanecarboxylic acid derivatives for the treatment of cognitive impairment
|
|
IN2014DN09031A
(https=)
|
2012-03-30 |
2015-05-22 |
Nuformix Ltd |
|
|
BR112015002309A2
(pt)
|
2012-08-07 |
2017-07-04 |
Buck Inst Res Aging |
formulação de múltiplos componentes para aprimorar a função neurológica
|
|
WO2014206898A1
(en)
|
2013-06-24 |
2014-12-31 |
Chiesi Farmaceutici S.P.A. |
Improved process for the preparation of derivatives of 1-(2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid
|
|
WO2015173133A1
(en)
|
2014-05-12 |
2015-11-19 |
Chiesi Farmaceutici S.P.A. |
Formulations and methods of treating alzheimer's disease and other proteinopathies by combination therapy
|
|
AU2022338032A1
(en)
*
|
2021-08-31 |
2024-03-07 |
Cerespir Incorporated |
Co-crystals
|